KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com) has received allowance of its U.S. patent application, protecting therapeutic agents based on a novel photoactive analog of its lead photodynamic product PH-10, from the United States Patent and Trademark Office (USPTO).
